Chemomab Therapeutics (CMMB) Return on Capital Employed [ROCE] (2019 - 2026)
Chemomab Therapeutics (CMMB) posted Return on Capital Employed [ROCE] of 79.76% for Q2 2026, down 32.40 percentage points from 112.16% a year earlier but up 16.11 percentage points from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends
For FY2025, Chemomab Therapeutics' Return on Capital Employed [ROCE] came in at 64.67%, down 20.68 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a four-year change of +29.47 percentage points (FY2021 to FY2025).
- In prior years, Chemomab Therapeutics' Return on Capital Employed [ROCE] was 85.35% in FY2024 (+2.58 pp), 82.76% in FY2023 (+23.51 pp), 59.26% in FY2022 (+24.06 pp) and 35.20% in FY2021.
- Quarterly Return on Capital Employed [ROCE] has run from a low of -16.40% in Q3 2021 to a high of 135.80% in Q3 2023 over five years.
- On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last nine quarters, with an average year-over-year change of -23.44 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q2 2023, with a gain of 92.87 percentage points; the weakest was Q1 2026, with a drop of 42.33 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was 63.65% (Q1 2026), 77.46% (Q4 2025) and 95.04% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Chemomab Therapeutics | 10.28 Mn | 10.28 Mn | - | 79.76% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.76% |
| Mar 31, 2026 | 63.65% |
| Dec 31, 2025 | 77.46% |
| Sep 30, 2025 | 95.04% |
| Jun 30, 2025 | 112.16% |
| Mar 31, 2025 | 105.97% |
| Dec 31, 2024 | 88.75% |
| Sep 30, 2024 | 104.46% |
| Jun 30, 2024 | 120.23% |
| Mar 31, 2024 | 117.56% |
| Dec 31, 2023 | 129.83% |
| Sep 30, 2023 | 135.80% |
| Jun 30, 2023 | 127.99% |
| Mar 31, 2023 | 98.85% |
| Dec 31, 2022 | 44.71% |
| Sep 30, 2022 | 62.47% |
| Jun 30, 2022 | 35.12% |
| Mar 31, 2022 | 15.35% |
| Dec 31, 2021 | 7.87% |
| Sep 30, 2021 | -16.40% |
API Access
Chemomab Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();